Lilly Cuts Low-Dose Zepbound Price
Digest more
Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic ...
The five-year SURMOUNT-REAL UK trial, part of a collaboration signed last year between Lilly and the UK government, will ...
Previous mega blockbusters took years to reach their peak sales. Lilly’s tirzepatide franchise is on course to exceed them ...
Lilly recently announced billion-dollar investments in manufacturing capacity in Puerto Rico and in Europe to support the ...
Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...
Eli Lilly has become the first healthcare company to hit a $1 trillion market value, entering an exclusive club dominated by ...
Lilly breaking through the $1tn market cap ceiling comes as investors have increasingly turned to pharma stocks. The S&P 500 ...
While Novo Nordisk and Pfizer intensify their plays, Lilly’s early lead in GLP-1 treatments has put it in a category all its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback